Randomized Trial: Effect of Low-Dose Vasopressin on Need for Transfusions in Patients With Trauma and Hemorrhagic Shock
29 Aug, 2019 | 06:45h | UTCEffect of Low-Dose Supplementation of Arginine Vasopressin on Need for Blood Product Transfusions in Patients With Trauma and Hemorrhagic Shock: A Randomized Clinical Trial – JAMA Surgery (free for a limited period)
Commentaries: Vasopressin as an Early Adjunct to Resuscitation in Hemorrhagic Shock: Crisis AVERTed? – JAMA Surgery (free) AND Giving trauma patients blood pressure stabilizing hormone cuts transfusions by half – University of Pennsylvania School of Medicine (free)
Author Interview: Arginine Vasopressin Supplementation in Early Traumatic Shock (free)
“Additional research is necessary to determine whether including AVP improves morbidity or mortality.”